Arkadios Wealth Advisors’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-137
Closed -$6K – 726
2021
Q3
$6K Sell
137
-361
-72% -$17.6K ﹤0.01% 1548
2021
Q2
$24K Buy
498
+436
+703% +$20.8K ﹤0.01% 1199
2021
Q1
$2K Sell
62
-93
-60% -$4.41K ﹤0.01% 1503
2020
Q4
$7K Buy
+155
New +$7.03K ﹤0.01% 1036
2020
Q2
– Sell
-74
Closed -$2.67K – 968
2020
Q1
$2.67K Buy
+74
New +$2.95K ﹤0.01% 894

Other funds holding BME

Arkadios Wealth Advisors's BME Position: Q4 2021 in Review

Arkadios Wealth Advisors sold out of BlackRock Health Sciences Trust (BME) in Q4 2021, closing a stake of 137 shares — an estimated $6K sold.

Arkadios Wealth Advisors first reported a position in BME in Q1 2020 and held it in 5 quarters. The position peaked at $24K in Q2 2021. 60 funds tracked by Wall St. Rank hold BME as of Q4 2021.

  • Arkadios Wealth Advisors reported no remaining BlackRock Health Sciences Trust position as of Q4 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 137 BlackRock Health Sciences Trust shares in Q4 2021, an estimated $6K.
  • Arkadios Wealth Advisors first reported a position in BlackRock Health Sciences Trust in Q1 2020 and held it in 5 quarters.
  • Arkadios Wealth Advisors's BlackRock Health Sciences Trust position peaked at $24K in Q2 2021.
  • 60 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q4 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q4 2021, filed 3 Feb 2022.